Amgen Inc. (AMGN)

$ 465.67
   
  • Change Today:
    $-1.39
  • 52 Week High: $480.99
  • 52 Week Low: $313.85
  • Currency: US Dollars
  • Shares Issued: 538.80m
  • Volume: 2,122,345
  • Market Cap: $250,903m
  • RiskGrade: 100
  • Beta: 0.02

Latest ShareCast News

Amgen buys UK biotech Dark Blue Therapeutics for up to $840m

By Michele Maatouk

Date: Tuesday 06 Jan 2026

(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 465.67
Change Today $ -1.39
% Change -0.30 %
52 Week High $480.99
52 Week Low $313.85
Volume 2,122,345
Shares Issued 538.80m
Market Cap $250,903m
Beta 0.02
RiskGrade 100

What The Brokers Say

Strong Buy 5
Buy 7
Neutral 17
Sell 3
Strong Sell 1
Total 33
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Nov-2026

Time Volume / Share Price
15:59 104 @ $465.65
15:59 100 @ $465.61
15:59 40 @ $465.61
15:59 44 @ $465.80
15:59 120 @ $465.77

Top of Page